News (31)

Hutchmed China to shift strategy toward advanced assets in pipeline AN
HUTCHMED Announces Strategy to Focus on Late-Stage Pipeline Regulatory Approvals GL
HUTCHMED Announces Strategy to Focus on Late-Stage Pipeline Regulatory Approvals AQ
Transcript : HUTCHMED Limited - Special Call
HUTCHMED China : Announces that Fruquintinib Global Phase III FRESCO-2 Study Has Met Its Primary Endpoint in Metastatic Colorectal Cancer - Form 6-K PU
HUTCHMED Announces that Fruquintinib Global Phase III FRESCO-2 Study Has Met Its Primary Endpoint in Metastatic Colorectal Cancer GL
HUTCHMED Announces that Fruquintinib Global Phase III FRESCO-2 Study Has Met Its Primary Endpoint in Metastatic Colorectal Cancer AQ
Transcript : HUTCHMED Limited, H1 2022 Earnings Call, Aug 01, 2022
Transcript : HUTCHMED Limited - Special Call
HUTCHMED China : INSIDE INFORMATION - Form 6-K PU
HUTCHMED Receives Complete Response Letter from the U.S. FDA for Surufatinib for the Treatment of Advanced Neuroendocrine Tumors GL
Transcript : HUTCHMED Limited, 2021 Earnings Call, Mar 03, 2022
Olympics-China reports 34 new COVID-19 cases among Games-related personnel RE
HUTCHMED China : Completes Planned Enrollment of FRESCO-2, a Global Phase III Trial of Fruquintinib in Metastatic Colorectal Cancer - Form 6-K PU
HUTCHMED Completes Planned Enrollment of FRESCO-2, a Global Phase III Trial of Fruquintinib in Metastatic Colorectal Cancer AQ
Transcript : HUTCHMED Limited, Q2 2021 Earnings Call, Jul 28, 2021
HUTCHMED China : Expands potential global reach of surufatinib, in addition to China where it is already launched, and in the U.S. where it is under review for marketing approval (Form 6-K) PU
HUTCHMED China : Marketing Authorization Application for Surufatinib Submitted and Validated by the European Medicines Agency AQ
HUTCHMED China : U.S. FDA Accepts Filing of HUTCHMED’s NDA for Surufatinib for the Treatment of Advanced Neuroendocrine Tumors (Form 6-K) PU
U.S. FDA Accepts Filing of HUTCHMED’s NDA for Surufatinib for the Treatment of Advanced Neuroendocrine Tumors GL
Transcript : HUTCHMED Limited - Special Call
Transcript : HUTCHMED Limited - Special Call
Hutchison China MediTech : HUTCHMED Completes Rolling Submission of NDA to U.S. FDA for Surufatinib for the Treatment of Advanced Neuroendocrine Tumors AQ
Transcript : Hutchison China MediTech Limited, 2020 Earnings Call, Mar 04, 2021
Chi-Med Initiates Rolling Submission of NDA to U.S. FDA for Surufatinib for the Treatment of Advanced Neuroendocrine Tumors GL
Transcript : Hutchison China MediTech Limited - Special Call
Eli Lilly and : Hutchison China MediTech Limited - Chi-Med and BeiGene Enter into Clinical Collaboration to Evaluate Combinations of Surufatinib and Fruquintinib with Tislelizumab AQ
Chi-Med and BeiGene Enter into Clinical Collaboration to Evaluate Combinations of Surufatinib and Fruquintinib with Tislelizumab GL
Transcript : Hutchison China MediTech Limited, 2019 Earnings Call, Mar 03, 2020
Transcript : Hutchison China MediTech Limited - Special Call
Transcript : Hutchison China MediTech Limited, 2018 Earnings Call, Mar 11, 2019

Insiders

Picture Marek Kania
Marek Kania

Presently, Marek Kania occupies the position of Chief Medical Officer & Managing Director at Hutchison China MediTech Ltd. Dr. Kania is also Member of American Society of Clinical Oncology and Member of American Association for Cancer Research. Dr. Kania received an MBA from The University of Chicago Booth School of Business.



Picture Marek Rejmer
Marek Rejmer

Marek Rejmer is currently the Senior VP-Identity & Access Management at Nixu Oyj since 2023.
Prior to this, he worked as the Group Chief Investment Officer at Telia Co. AB.


Picture Marek Kapuscinski
Marek Kapuscinski

Currently, Marek Kapuscinski occupies the position of Chairman-Supervisory Board for Cyfrowy Polsat SA. Mr. Kapuscinski is also on the board of Bank Handlowy w Warszawie SA and Cydrownia SA. He previously held the position of Marketing Director at Procter & Gamble Co. Mr. Kapuscinski received a graduate degree from Warsaw School of Economics and an undergraduate degree from New York University.


Picture Marek Leszek Piechocki
Marek Leszek Piechocki

Founder of LPP SA, Marek Leszek Piechocki presently is Chairman-Management Board at this company. Mr. Piechocki is also on the board of Family Investments 3 Sp zoo. He previously held the position of Chairman-Management Board at Tora Sp zoo, President-Management Board of BBK SA and Partner at DH Market SC. Mr. Piechocki received an undergraduate degree from Politechnika Gdanska.


Picture Marek Grzegorz Lusztyn
Marek Grzegorz Lusztyn

Marek Grzegorz Lusztyn is on the board of Pekao Leasing Sp zoo. Dr. Lusztyn previously held the position of Senior Vice President for UniCredit SpA. Dr. Lusztyn received a doctorate from Warsaw School of Economics and an MBA from the University of Illinois.


Picture Henryk Marek Kania
Henryk Marek Kania

Henryk Marek Kania founded Zaklady Miesne Henryk Kania SA in 1990, where he is working as Member-Supervisory Board.
Mr. Kania also formerly worked at NWAI Dom Maklerski SA, as Member-Supervisory Board.


Picture Piotr Kania
Piotr Kania

Piotr Kania is currently a member of the supervisory board at Fintech SA and Global Trans SA. He was previously the sales director at Pyramed Sp zoo from 2012 to 2015 and the managing director at Amed Zaklad Aparatury Medycznej from 2015 to 2018.


Picture Ryan Kania
Ryan Kania

Ryan Kania is the founder and CEO of Advocates for World Health, Inc. which is founded in 2008.
He is currently a board member at Seedfunders LLC since 2019.
Mr. Kania completed his undergraduate degree at the University of South Florida in 2010 and is currently pursuing an MBA at Kellogg School of Management.








Picture Paul Kania
Paul Kania

Mr. Paul L.
Kania
, CPA, is a Chief Executive & Financial Officer at SOL Global Investments Corp., a Chief Financial Officer at Belgravia Hartford Capital, Inc., a Chief Financial Officer at Arena Minerals, Inc., a Member at Certified Public Accountants & Advisors, a Member at New York State Society of Certified Public Accountants, a President & Director at House of Lithium Ltd., a Principal at Koral Financial, Inc. and a Principal at Plk Accounting & Finance, Inc. He is on the Board of Directors at House of Lithium Ltd.
Mr. Kania was previously employed as a Chief Financial Officer by KWESST Micro Systems, Inc., a Chief Financial Officer by Clear Blue Technologies International, Inc., a Chief Financial Officer by UGE International Ltd., a Chief Financial Officer & Secretary by Dragonfly Capital Corp., a Chief Financial Officer by BLACKROCK GOLD CORP, a Chief Financial Officer by GT Gold Corp., an Auditor by Berdon LLP, and an Auditor by MNP LLP.
He also served on the board at Tantalex Resources Corp.
He received his undergraduate degree from the University of Toronto.










Picture Kania Dewana Warbington
Kania Dewana Warbington

Kania Dewana Warbington worked as a Secretary at the Federal Home Loan Bank of Indianapolis from 2011 to 2019.





Picture Nia Kania
Nia Kania

Nia Kania is currently working as the Director-Finance & Risk Management at PT Bank Pembangunan Daerah Jawa Barat dan Banten Tbk.
She completed her undergraduate degree at Universitas Padjadjaran in 1990 and her graduate degree in 2020.






Picture Ed Kania
Ed Kania

Ed M.
Kania
is the founder of Flagship Pioneering, which was founded in 1999.
He is also the founder of Health Data Analytics Institute, Inc. Mr. Kania's current job titles include Chairman at Vyriad, Inc., Chairman & Managing Partner at Farfield Partners, Director at EcoSense Lighting, Inc., Director at G6 Capital Management LLC, Director at DataCore Software Corp., Director at TransMedics, Inc., Director at Massachusetts Biotechnology Council, Independent Director at TransMedics Group, Inc., and Director at Korrus, Inc. Mr. Kania's former job titles include Chairman at VisEn Medical, Inc., Co-Chairman at Common Impact, Inc., Director at Aspect Medical Systems, Inc., Director at EXACT Sciences Corp., Director at Epitome Biosystems, Inc., Independent Director at Acceleron Pharma, Inc., Director at MedidaMetrics, Inc., Director at INTIO LLC, Director at Interactive Supercomputing, Inc., Director at Pangea DiamondFields Plc, Director at Visterra, Inc., Director at TARIS BioMedical LLC, Independent Director at Selecta Biosciences, Inc., Director at Nanostream, Inc., Director at Oasys Water, Inc., Director at Tarveda Therapeutics, Inc., Managing Partner at One Liberty Ventures, General Partner at Oneliberty Ventures Inc., and Research Associate at Harvard Business School.
Mr. Kania's education includes an undergraduate degree from Dartmouth College in 1979 and an MBA from Harvard Business School in 1982.



Picture Donald Kania
Donald Kania

Donald R.
Kania
is currently the Chairman at DNA Script SAS, LUMICKS Technologies Bv, and Gandeeva Therapeutics, Inc. He is also a Director at Leupold & Stevens, Inc., SEMI North America, Matrix Sensors, Inc., Lumicks BV, and a Trustee at Pacific University.
Previously, he served as the President, Chief Executive Officer & Director at FEI Co. from 2006 to 2016, an Independent Non-Employee Director at American Science & Engineering, Inc. from 2010 to 2016, and a Research Director at Crystallume from 1991 to 1993.
He has also held positions as a Director at Aldevron LLC, a Research Director at Los Alamos National Laboratory from 1987 to 1991, an Independent Director at NanoString Technologies, Inc. from 2019 to 2022, an Independent Director at Intuitive Surgical, Inc. from 2018 to 2024, the President & Chief Operating Officer at Veeco Instruments, Inc. in 2006, a Senior Manager at Lawrence Livermore National Laboratory from 1993 to 1998, the President of Veeco Metrology Group from 2000 to 2003, and the Vice President & General Manager at California Metrology Group from 1999 to 2000.
He is also a Trustee at Oregon Health & Science University Foundation.
Dr. Kania completed his undergraduate, graduate, and doctorate degrees at the University of Michigan.



Picture Antoni Kania
Antoni Kania

Antoni Kania has a current job as an Analyst at mBank SA (Broker) since 2021.


Picture Chase Kania
Chase Kania

Chase Kania currently works at Earth Finance, Inc., as Director from 2023.



Picture Carol Ann Kania
Carol Ann Kania

Carol Ann Kania has a current job as a Trustee at the Museum of Science.









Picture Tomasz Kania
Tomasz Kania

Tomasz Kania worked as a Chief Operating Officer at Fagron NV.



Picture Florian Alexander Kania
Florian Alexander Kania

Florian Alexander Kania has worked as a Director at MB Global Health Ltd.
since 2018.







Picture Robert F. Kania
Robert F. Kania

Mr. Robert F.
Kania
, Jr. CFA, is Vice President & Senior Portfolio Manager at SSgA Funds Management, Inc. Prior to joining SSgA Funds Management in 2000, he worked as a portfolio manager and analyst at Fleet Investment Advisors in Boston.
Preceding this, he managed the investment-grade sovereign fixed income research effort for Lehman Brothers in New York.
He has been working in the investment management field since 1990.
He also worked for Putnam Investments.
Mr. Kania received a BA from the College of the Holy Cross.
He has earned the Chartered Financial Analyst designation.
He is a member of the Boston Security Analysts Society and CFA Institute.


Picture Joseph Kanja Kania
Joseph Kanja Kania

Joseph Kanja Kania is currently working as a Secretary at KCB (Sudan) Ltd.
and as an Associate Member at Chartered Institute of Arbitrators (Kenya).
He has previously worked as a Secretary at KCB Group Plc, Secretary & Assistant General Manager-Legal at HF Group Plc, Senior Legal Officer at Industrial & Commercial Development Corp.
and Legal Officer at Southern Credit Banking Corp.
Ltd.
Mr. Kania is a graduate from the University of Nairobi.
















Picture Steffen Kania
Steffen Kania

Steffen Kania has held positions as Chairman-Supervisory Board at Wohnungsbau - und Verwaltungsgesellschaft Saalfeld and Saalfelder Bäder GmbH.


Picture Steffen Kania
Steffen Kania

Steffen Kania currently holds a position as a Member-Supervisory Board at Arbeiter Wohlfahrt Alten Jugend und Sozialhilfe gGmbH.



Picture Evanthia Kania
Evanthia Kania

Evanthia Kania currently works as a General Manager at GPB Financial Services Ltd.



Picture Pawel Kania
Pawel Kania

Pawel Kania is the founder of Karcz i Kania, established in 2009.
He is currently the Vice Chairman-Supervisory Board at Via Sp.
z.o.o.
since 2006, a Member-Supervisory Board at Grupa Edukacyjna SA since 2007, a Legal Counsel & Member at Okregowa Izba Radcow Prawnych w Kielcach since 2004, the Managing Partner at Kania i Partnerzy since 2013, the Managing Partner at Konkowski Kania Walczyk Bialy since 2005, and the Secretary-Supervisory Board at Wydawnictwo JUKA-91.
sp.
since 2006.
He previously served as Secretary-Supervisory Board at Wytwornia Sprzetu Komunikacyjnego PZL-KROSNO SA and as a Member-Supervisory Board at BGE SA. Mr. Kania graduated from Uniwersytet Jagiellonski in 1997.


Picture Alex Kania
Alex Kania

Alex Kania is currently working as a Lead Analyst at Marathon Capital LLC.
Prior to this, he worked as a Director & Senior Analyst at Wolfe Research LLC.
He also worked as an Associate at Deutsche Bank Securities, Inc. from 2003 to 2004 and as a Research Analyst at Merrill Lynch, Pierce, Fenner & Smith, Inc. from 2005 to 2012.
Mr. Kania completed his undergraduate degree from Brandeis University.






Picture Kania D. Warbington Lottie
Kania D. Warbington Lottie

Kania D.
Warbington Lottie
has a current job as the Chief Human Resource Officer & Senior VP at the Federal Home Loan Bank of Indianapolis.





Picture Grzegorz Julian Kania
Grzegorz Julian Kania

Grzegorz Julian Kania is currently a member of the supervisory board at Art Marketing Syndicate SA, a member of the Association of Chartered Certified Accountants, and the Chief Financial Officer at Ringier Axel Springer Polska Sp zoo.
He was previously a member of the management board at Agora SA, the Chief Financial Officer at Grupa Onet SA, BLStream Oy, and Huuuge, Inc., and the Deputy Chief Financial Officer at UPC Polska Sp zoo.
He also served as a member of the supervisory board at Stopklatka SA and Onet-Ras Poland.
Kania holds a graduate degree from Politechnika Wroclawska and Wroclaw University of Science & Technology.





Picture Tadeusz Roman Kania
Tadeusz Roman Kania

Tadeusz Roman Kania currently holds positions in Lumiere Sp zoo as a Member-Supervisory Board member.


Picture Andrzej Józef Kania
Andrzej Józef Kania

Andrzej Józef Kania served as the Chairman-Supervisory Board at TAURON Polska Energia SA from 2020 to 2021.
He also worked as a Member-Supervisory Board at Polimex-Mostostal SA.








Picture Marek Juda
Marek Juda

Marek Juda formerly worked at Atos Polska SA, as Chief Executive Officer, Oberthur Technologies SA, as Managing Director-Solutions Business Unit, and Accenture LLP, as Consultant.

No results for this search